Founded at the Abramson Cancer Center at the University of Pennsylvania

Comparative toxicity outcomes of proton‐beam therapy versus intensity‐modulated radiotherapy for prostate cancer in the postoperative setting

Comparative toxicity outcomes of proton‐beam therapy versus intensity‐modulated radiotherapy for prostate cancer in the postoperative setting

Cancer | 2019

Patricia Mae G. Santos, MD, MS; Andrew R. Barsky, MD; Wei‐Ting Hwang, PhD; Curtiland Deville, MD; Xingmei Wang, MS; Stefan Both, PhD; Justin E. Bekelman, MD; John P. Christodouleas, MD, MPH; Neha Vapiwala, MD